Evidence map›Paper›PMID 42799847›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2027

Identification of Mycoviral Infections.

Ana Ruiz-Padilla, Julio L Rodríguez-Romero, Marco Chiapello, María A Ayllón

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ana Ruiz-PadillaCentro de Biotecnología y Genómica de Plantas, Universidad Politécnica de Madrid (UPM)-Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Campus de Montegancedo, Pozuelo de Alarcón, Madrid, Spain.
Julio L Rodríguez-RomeroCentro de Biotecnología y Genómica de Plantas, Universidad Politécnica de Madrid (UPM)-Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Campus de Montegancedo, Pozuelo de Alarcón, Madrid, Spain.
Marco ChiapelloInstitute for Sustainable Plant Protection, National Research Council of Italy, Turin, Italy.
María A AyllónCentro de Biotecnología y Genómica de Plantas, Universidad Politécnica de Madrid (UPM)-Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Campus de Montegancedo, Pozuelo de Alarcón, Madrid, Spain. mariaangeles.ayllon@upm.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-throughput sequencing of total RNA has permitted the detection of novel mycoviruses in fungi with different types of genomes, including mycoviruses with double-stranded RNA, single-stranded positive- or negative-stranded RNA, or single-stranded DNA genomes. However, in silico detection of mycoviruses is not always sufficient to guarantee their presence in sequenced samples, especially in the case of the discovery of unique mycoviruses, and additional analyses are required to validate in vivo the data obtained by bioinformatics analysis. This chapter provides comprehensive protocols for the extraction of total RNA from the plant pathogenic fungus Botrytis cinerea for next-generation sequencing (NGS), outlines the bioinformatics pipeline designed and followed to detect mycoviruses in the sequenced samples, and details the detection in vivo and the complete molecular characterization of the mycoviruses identified in silico.

Indexed as

BotrytisFungal VirusesComputational BiologyGenome, ViralHigh-Throughput Nucleotide SequencingMetagenomicsRNA, ViralRNA, ViralBioinformatic pipelineBotrytis cinereaMycovirusesNecrotrophic fungiNext-generation sequencing (NGS)Viral metagenomicsVirome

Identifiers

PMID42799847

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.